Asian Paints:₹2,640.80+0.79 (+0.03%)
Cipla:₹1,437.90+5.73 (+0.40%)
Eicher Motors:₹8,047.00+36.85 (+0.46%)
Nestle India:₹1,471.30-5.76 (-0.39%)
Grasim Inds:₹3,288.00-19.85 (-0.60%)
Hindalco Inds.:₹1,058.50+24.51 (+2.37%)
Hind. Unilever:₹2,030.00+14.91 (+0.74%)
ITC:₹269.70+0.30 (+0.11%)
Trent:₹2,905.00-19.01 (-0.65%)
Larsen & Toubro:₹4,090.00-2.87 (-0.07%)
M & M:₹3,414.10+2.05 (+0.06%)
Reliance Industries:₹1,309.80-6.19 (-0.47%)
Tata Consumer:₹1,062.50+13.53 (+1.29%)
Tata Motors PVeh:₹314.40-3.50 (-1.10%)
Tata Steel:₹186.30+3.29 (+1.80%)
Wipro:₹181.31+0.52 (+0.29%)
Apollo Hospitals:₹8,702.00+8.69 (+0.10%)
Dr Reddy's Labs:₹1,190.00+15.27 (+1.30%)
Titan Company:₹5,079.00-7.12 (-0.14%)
SBI:₹1,039.50-9.23 (-0.88%)
Shriram Finance:₹1,119.00-10.96 (-0.97%)
Bharat Electron:₹409.00-5.01 (-1.21%)
Kotak Mah. Bank:₹401.45-1.37 (-0.34%)
Infosys:₹1,130.00+8.97 (+0.80%)
Bajaj Finance:₹1,077.00-17.96 (-1.64%)
Adani Enterp.:₹2,998.60+1.50 (+0.05%)
Sun Pharma.Inds.:₹1,910.00+7.61 (+0.40%)
JSW Steel:₹1,327.00+33.25 (+2.57%)
HDFC Bank:₹729.00+2.04 (+0.28%)
TCS:₹2,284.10-17.96 (-0.78%)
ICICI Bank:₹1,415.00-4.97 (-0.35%)
Power Grid Corpn:₹271.40-1.01 (-0.37%)
Maruti Suzuki:₹13,620.00+55.61 (+0.41%)
Axis Bank:₹1,236.00-9.84 (-0.79%)
HCL Technologies:₹1,322.00+19.54 (+1.50%)
O N G C:₹236.55+0.14 (+0.06%)
NTPC:₹339.50-0.51 (-0.15%)
Coal India:₹406.90+1.70 (+0.42%)
Bharti Airtel:₹1,935.00-11.09 (-0.57%)
Tech Mahindra:₹1,584.00+0.00 (+0.00%)
Jio Financial:₹242.00-2.00 (-0.82%)
Adani Ports:₹1,672.10-27.88 (-1.64%)
HDFC Life Insur.:₹552.95-1.83 (-0.33%)
SBI Life Insuran:₹1,761.80-31.02 (-1.73%)
Max Healthcare:₹990.50-9.50 (-0.95%)
UltraTech Cem.:₹11,504.00-65.95 (-0.57%)
Bajaj Auto:₹11,800.00+99.45 (+0.85%)
Bajaj Finserv:₹2,001.70-30.90 (-1.52%)
Interglobe Aviat:₹5,115.00+5.11 (+0.10%)
Eternal:₹327.15-0.85 (-0.26%)
Asian Paints:₹2,640.80+0.79 (+0.03%)
Cipla:₹1,437.90+5.73 (+0.40%)
Eicher Motors:₹8,047.00+36.85 (+0.46%)
Nestle India:₹1,471.30-5.76 (-0.39%)
Grasim Inds:₹3,288.00-19.85 (-0.60%)
Hindalco Inds.:₹1,058.50+24.51 (+2.37%)
Hind. Unilever:₹2,030.00+14.91 (+0.74%)
ITC:₹269.70+0.30 (+0.11%)
Trent:₹2,905.00-19.01 (-0.65%)
Larsen & Toubro:₹4,090.00-2.87 (-0.07%)
M & M:₹3,414.10+2.05 (+0.06%)
Reliance Industries:₹1,309.80-6.19 (-0.47%)
Tata Consumer:₹1,062.50+13.53 (+1.29%)
Tata Motors PVeh:₹314.40-3.50 (-1.10%)
Tata Steel:₹186.30+3.29 (+1.80%)
Wipro:₹181.31+0.52 (+0.29%)
Apollo Hospitals:₹8,702.00+8.69 (+0.10%)
Dr Reddy's Labs:₹1,190.00+15.27 (+1.30%)
Titan Company:₹5,079.00-7.12 (-0.14%)
SBI:₹1,039.50-9.23 (-0.88%)
Shriram Finance:₹1,119.00-10.96 (-0.97%)
Bharat Electron:₹409.00-5.01 (-1.21%)
Kotak Mah. Bank:₹401.45-1.37 (-0.34%)
Infosys:₹1,130.00+8.97 (+0.80%)
Bajaj Finance:₹1,077.00-17.96 (-1.64%)
Adani Enterp.:₹2,998.60+1.50 (+0.05%)
Sun Pharma.Inds.:₹1,910.00+7.61 (+0.40%)
JSW Steel:₹1,327.00+33.25 (+2.57%)
HDFC Bank:₹729.00+2.04 (+0.28%)
TCS:₹2,284.10-17.96 (-0.78%)
ICICI Bank:₹1,415.00-4.97 (-0.35%)
Power Grid Corpn:₹271.40-1.01 (-0.37%)
Maruti Suzuki:₹13,620.00+55.61 (+0.41%)
Axis Bank:₹1,236.00-9.84 (-0.79%)
HCL Technologies:₹1,322.00+19.54 (+1.50%)
O N G C:₹236.55+0.14 (+0.06%)
NTPC:₹339.50-0.51 (-0.15%)
Coal India:₹406.90+1.70 (+0.42%)
Bharti Airtel:₹1,935.00-11.09 (-0.57%)
Tech Mahindra:₹1,584.00+0.00 (+0.00%)
Jio Financial:₹242.00-2.00 (-0.82%)
Adani Ports:₹1,672.10-27.88 (-1.64%)
HDFC Life Insur.:₹552.95-1.83 (-0.33%)
SBI Life Insuran:₹1,761.80-31.02 (-1.73%)
Max Healthcare:₹990.50-9.50 (-0.95%)
UltraTech Cem.:₹11,504.00-65.95 (-0.57%)
Bajaj Auto:₹11,800.00+99.45 (+0.85%)
Bajaj Finserv:₹2,001.70-30.90 (-1.52%)
Interglobe Aviat:₹5,115.00+5.11 (+0.10%)
Eternal:₹327.15-0.85 (-0.26%)
Arihant Plus App

Arihant Plus App

Marksans Pharma Ltd

Marksans Pharma | 524404

Market Closed
₹323.90
+₹2.60 (+0.81%)
As on 24/08/26, 11:11 PM
Market Cap14,560.15 CR
Current Price₹323.9
High / Low₹345.5 / 155
PE Ratio17.04
Book Value₹66.71
Dividend Yield0.57%
ROCE18.96%
ROE19.81%
Face Value₹2.00
Current Vol.17,94,290
Average Vol.---
ISININE750C01026
PB Ratio2.36
Debt to Equity0.12
Net Profit Margin14.23
Operating Margin23.16

MARKSANS - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹321.3₹322.6
₹323.9
Previous CloseToday's Open
₹155₹345.5
₹323.9
52W Low52W High
₹322.6Today's Open
₹321.3Previous Close
17,94,290Volume
₹15552W Low
₹345.552W High

Ratios

No data available

About Company

  • Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982
  • Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005
  • The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation
  • The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai
  • In 2004-05, the Company amalgamated with M/s
  • Marksans Pharma Limited, pursuant to High Court order dated 19th August, 2005
  • The Company acquired majority stake in Nova Pharmaceuticals Australasia Private Limited in 2005; further, it acquired two companies, Bell Sons & Company (Druggists) Limited and Relonchem Limited in the UK in 2008
  • The Company received first ANDA approval in the USA in 2011
  • It acquired Time-Cap Laboratories Inc
  • The Company launched the CNS-Cerebella division in FY 2017-18

Ethics: Marksans Pharma Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

worldwide image

Below average

The company's ESG practices are below average compared to its peers.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Log InSign Up

Technical Indicators

RSI67.80
SMA 20288.38
SMA 50272.48
SMA 100237.40
SMA 200208.43
SMA 10312.65
MACD_12_26_Days17.71
EMA10Day312.17
EMA20Day296.92
EMA50Day272.99
MACD_12_26_9_Days3.98
EMA100Day248.50
EMA200Day228.57

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth12.51%
ROE15.30%
EBITDA Margin23.16%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
2,950.94
2,622.85
2,177.41
1,852.14
1,490.84
Interest
24.13
11.66
11.20
9.13
8.45
Expenses
2,350.16
2,090.16
1,718.83
1,512.82
1,231.96
Financing Profit
683.31
599.01
509.00
398.63
300.73
Financing Margin %
23%
23%
23%
22%
20%
Other Income
82.53
66.33
50.42
59.31
41.85
Depreciation
98.63
83.39
74.27
51.85
44.78
Profit before tax
560.55
503.97
423.53
337.65
247.51
Tax %
25%
24%
26%
21%
25%
Net Profit
420.06
382.62
314.90
265.32
186.81
EPS in Rs
9.22
8.40
6.92
6.41
4.51
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
UNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI11 Jun ‘25Purchase32,47,600₹249.9583.40%
UTI MUTUAL FUND11 Jun ‘25Purchase4,14,093₹249.9510.63%
UNIFI CAPITAL PRIVATE LIMITED11 Jun ‘25Purchase5,94,000₹249.9515.25%
UNIFI BLEND FUND 211 Jun ‘25Purchase30,00,000₹249.9577.04%
UNIFI BCAD FUND11 Jun ‘25Purchase5,60,000₹249.9514.38%
SOCIETE GENERALE11 Jun ‘25Purchase9,20,184₹249.9523.63%
CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED11 Jun ‘25Purchase4,00,081₹249.9510.27%
BANDHAN MUTUAL FUND11 Jun ‘25Purchase6,00,000₹249.9515.41%
SUBHKAM VENTURES I PRIVATE LIMITED11 Jun ‘25Purchase5,37,485₹249.9513.80%
ORBIMED ASIA IV MAURITIUS FVCI LIMITED11 Jun ‘25Sell1,02,73,443₹249.95263.83%

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
20 Aug 2026
Final Dividend (₹0.9)
Further, kindly be informed that the Board has recommended a final dividend of Rs. 0.90 per Equity Share of face value of Re. 1/- per share (90%) for the financial year 2025-26. The dividend, if approved by the Members at the forthcoming Annual General Meeting ('AGM') will be credited / dispatched within 30 days from the date of AGM. The Board of Directors of Marksans Pharma Limited fixed 20 August 2026 as the Record Date for payment of dividend. (As per BSE Announcement dated on: 03.07.2026)
26 May 2026
08 Aug 2025
AGM
AGM
11 Jul 2025
01 Aug 2025
Final Dividend (₹0.8)
Recommended a final dividend of Rs. 0.80 per Equity Share (face value Re. 1 per share) for the financial year 2024-25. The dividend, if approved by the Members at the forthcoming Annual General Meeting ('AGM') will be credited / dispatched within 30 days from the date of AGM he Company has fixed Friday, August 01, 2025 as the Record Date for determining eligibility of Members to receive final dividend for the financial year ended March 31, 2025. The Board, at its meeting held on May 19, 2025, has recommended a final dividend of ? 0.80/- (80%) per equity share of face value of ? 1/- each for the financial year ended March 31, 2025, subject to approval of Members of the Company at the ensuing AGM. (As Per BSE Announcement Dated on 11.07.2025)
19 May 2025
24 Sept 2024
AGM
AGM
19 Aug 2024
17 Sept 2024
Final Dividend (₹0.6)
The Board has approved final dividend of Rs. 0.60 per equity share
30 May 2024
28 Aug 2023
AGM
AGM
02 Aug 2023
07 Jun 2023
Final Dividend (₹0.5)
Declaration of dividend @ Re. 0.50 (Rupee Zero and Paise Fifty) i.e. 50% per equity share ofRe. 1/- each face value for the financial year 2022-23 have been approved by the Board of Directors. The payment of the dividend shall be made on or after 12th June, 2023 to all the members of the Company whose names has been entered on Record Date i.e 7thJune, 2023.
30 May 2023
29 Aug 2022
AGM
AGM
29 Jul 2022
23 Aug 2022
Final Dividend (₹0.25)
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended final dividend @ Re. 0.25 (Rupee Zero and Paise Twenty Five) i.e. 25% per equity share of Re. 1/- each face value for the financial year ended March 31, 2022, subject to approval of the shareholders in the ensuing Annual General Meeting.
30 May 2022
15 Jul 2022
Buyback
Open Market Purchase - Max Price: ₹60, Amount: ₹60Cr
08 Jul 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
324
14,683
28
5
24
0
14.23%
1,910
4,58,249
36
5
29
0
19.78%
8,500
2,25,648
76
13
65
0
24.32%
4,861
1,84,891
83
22
49
1
11.09%
1,435
1,15,927
32
3
24
0
9.92%
1,101
1,09,825
22
4
17
0
9.82%
2,190
1,00,134
17
4
13
0
19.16%
1,195
99,702
31
3
19
0
12.34%
2,375
98,087
46
6
32
0
13.57%
1,796
97,054
89
18
61
1
13.06%
Showing 10 of 139 Results

Frequently Asked Questions

What is Share Price of Marksans Pharma Ltd?

The current share price of Marksans Pharma Ltd (Marksans Pharma) is ₹323.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Marksans Pharma Ltd?

The Price-to-Earnings (P/E) ratio of Marksans Pharma Ltd is 323.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Marksans Pharma Ltd?

Marksans Pharma Ltd has a 52-week high of ₹345.50 and a 52-week low of ₹155.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Marksans Pharma Ltd?

Marksans Pharma Ltd offers a dividend yield of 0.28%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Marksans Pharma Ltd?

The Earnings Per Share (EPS) of Marksans Pharma Ltd is ₹11.40. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Marksans Pharma Ltd?

Marksans Pharma Ltd has a Return on Equity (ROE) of 19.81%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2